COULTER ACT 5 DIFF ANALYZER
Report
- Report Number
- 1061932-2009-00001
- Event Type
- Other
- Date Received
- January 16, 2009
- Date of Event
- December 15, 2008
- Report Date
- January 16, 2009
- Manufacturer
- BECKMAN COULTER, INC.
- Product Code
- GKZ
- PMA / PMN Number
- K003677
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
Narratives
SAMPLES WERE DRAWN IN 4 ML EDTA VACUTAINERS AND ANALYZED THE SAME DAY. QC IS RUN DAILY AND THE INSTRUMENT RECOVERED WITHIN QC SPECIFICATIONS. THE FIELD SERVICE ENGINEER (FSE) CONFIRMED THE PROBLEM BY RUNNING REPRODUCIBILITY. THE FSE REBUILT THE SAMPLE AND REAGENT SYRINGES, CHECKED TRAVERSE BELT TENSION, LUBED RAILS, ADJUSTED CARRIAGE STOP COLLAR, CHECKED PROBE ALIGNMENT, AND VERIFIED CONDITION OF PROBE. AS OF 2009, NO FURTHER LOW/ERRATIC RESULTS HAVE BEEN REPORTED. A CLEAR ROOT CAUSE HAS NOT BEEN DETERMINED TO DATE FOR THIS EVENT. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.
A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING ERRONEOUSLY LOW PLATELET (PLT) AND HEMOGLOBIN (HGB) RESULTS PRODUCED BY THE COULTER ACT 5 DIFF ANALYZER. SEVERAL PT SAMPLES WERE TESTED FOR PLT AND GAVE RESULTS IN THE RANGE OF 121 - 320 X 10^3 CELLS/ML. THESE SAMPLES WERE ALSO TESTED FOR HGB AND GAVE RESULTS IN THE RANGE OF 8.7 - 16.8G/DL. SAMPLE ONE WHEN TESTED ON THE COULTER ACT 5 DIFF ANALYZER GAVE A PLT RESULT OF 144 X 10 TO THE THIRD POWER CELLS/ML AND AN HGB RESULT OF 10.2G/DL. IT WAS TESTED IN A REFERENCE LAB UPON WHICH IT GAVE A PLT RESULT OF 189 X 10^3 CELLS/ML AND A HGB RESULT OF 13.2G/DL WHICH WERE CONSIDERED CORRECT. THE ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. IT IS UNK IF THERE WAS AN AFFECT TO PT OR USER WITH REGARDS TO THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COULTER ACT 5 DIFF ANALYZER | AUTOMATED DIFFERENTIAL CELL COUNTER | GKZ | BECKMAN COULTER, INC. | ACT 5 DIFF CP | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA |